Company profile: Berlin Heals
1.1 - Company Overview
Company description
- Provider of implantable medical devices for the treatment of heart failure, including the C-MIC Device, which delivers a constant, minimal electrical direct current to the heart to promote reverse remodeling of cardiac muscle tissue in heart failure patients.
Products and services
- C-MIC Device: An implantable, medical-grade device that delivers constant, minimal direct current to the heart, promoting reverse remodeling of cardiac muscle tissue in heart failure patients
- Implantable Medical Device Development: Berlin Heals develops custom-engineered implantable cardiac products targeting heart ailments, with a focus on devices for the cure and treatment of heart failure
- Healthcare Equipment Manufacturing: The company fabricates industrial-grade implantable medical devices for cardiac care, building products intended to address heart ailments and heart failure through implanted therapeutic hardware
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Berlin Heals
Vascular Concepts
HQ: India
Website
- Description: Provider of cutting-edge medical devices for the treatment of arterial diseases that are affordable for the common man.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Concepts company profile →
Vdyne
HQ: United States
Website
- Description: Provider of proprietary transcatheter valve technology to treat tricuspid regurgitation via a unique side-delivery method, enabling treatment for a broader patient population; developing tricuspid replacement valve and repair technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vdyne company profile →
XO1
HQ: United Kingdom
Website
- Description: Provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XO1 company profile →
Remote Diagnostic Technologies
HQ: United Kingdom
Website
- Description: Provider of advanced pre-hospital monitoring, cardiac therapy and data management solutions, including compact, integrated vital signs monitors and defibrillators such as Tempus ALS (Tempus Pro + Tempus LS), HeartStart Intrepid, Efficia DFM100, Tempus IC2 and Tempus Pro, plus Q-CPR measurement and feedback for improved CPR and telemedicine for remote emergencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Remote Diagnostic Technologies company profile →
CiVi Biopharma
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology research and development focused on novel cardiovascular therapies, including CiVi 008, an oral PCSK9-targeting treatment to lower LDL cholesterol and prevent atherosclerotic cardiovascular disease, and CiVi 030, an intravenous iloprost formulation for severe frostbite with vasodilator, platelet inhibitor, anti-inflammatory, and anti-fibrotic effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CiVi Biopharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Berlin Heals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Berlin Heals
2.2 - Growth funds investing in similar companies to Berlin Heals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Berlin Heals
4.2 - Public trading comparable groups for Berlin Heals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →